Cell communication and signaling : CCS
Harnessing nanomedicine to target NF-κB signalling in cancer: at the intersection of inflammatory signalling, metabolic reprogramming, and therapeutic innovation.
Bandari BharathwajChetty, Babu Santha Aswani, Shweta S Shinde, Mohammed S Alqahtani, Mohamed Abbas, Gautam Sethi, Zhaowu Ma, Ajaikumar B Kunnumakkara
Published: 202610.1186/s12964-025-02554-9
No abstract available for this study.